Showing 1601-1610 of 2150 results for "".
- ReFocus Eye Health Acquires OptiCare Eye Health & Vision Centershttps://modernod.com/news/refocus-eye-health-acquires-opticare-eye-health-vision-centers/2478105/ReFocus Eye Health has announced the acquisition of OptiCare Eye Health & Vision Centers. Terms of the deal were not disclosed. “We couldn’t be more excited about the surgeons and staff of OptiCare becoming part of the ReFocus family,”
- New Topline Tepezza Data Underscore its Efficacy in Potential for Retreatment in People Living with Thyroid Eye Disease (TED)https://modernod.com/news/new-topline-tepezza-data-underscore-its-efficacy-in-potential-for-retreatment-in-people-living-with-thyroid-eye-disease-ted/2478101/Horizon Therapeutics announced positive topline data from two clinical trials that add to the growing body of evidence supporting the efficacy and safety of Tepezza (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED). Tepezza is the first and only medicine approved by the FDA for t
- Ocutrx Says It Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021https://modernod.com/news/ocutrx-says-it-will-deliver-worlds-first-5g-ar-xr-medical-specific-platform-in-2021/2477980/Ocutrx Vision Technologies announced plans to deliver the first AR headsets specific for medical applications providing connectivity from AT&T and using 5G products from Qualcomm Technologies. Ocutrx is building its AR/XR medical device, the Oculenz headset, for patient use; and a seco
- CDC Broadens Guidance on Americans Facing Risk of Severe COVID-19https://modernod.com/news/cdc-broadens-guidance-on-americans-facing-risk-of-severe-covid-19/2477936/The Centers for Disease Control and Prevention on Thursday broadened its warning about who is at risk of developing severe disease from COVID-19 infection, suggesting even younger people who are obese or have other health conditions can become seriously ill if they contract the virus, according t
- American Medical Association’s New President a ‘Passionate Defender of the Independent Physician’https://modernod.com/news/american-medical-associations-new-president-a-passionate-defender-of-the-independent-physician/2477875/Susan Bailey, MD, the new president of the American Medical Association (AMA), called for physicians to advocate at the highest levels of government and insurance companies for support needed “to sustain private practice during a pandemic that threatens its very survival,” according t
- Roche Antibody Test for COVID-19 Goes Live at More Than 20 Initial Lab Sites in the UShttps://modernod.com/news/roche-antibody-test-for-covid-19-goes-live-at-more-than-20-initial-lab-sites-in-the-us/2477797/Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab sites throughout the United States, with plans in the next several weeks to increase to more than 200 commercial and hospital lab sites with the ability t
- Regeneron CEO: Manufacturing Not Up to Snuff for COVID-19 Vaccines, Therapieshttps://modernod.com/news/regeneron-ceo-manufacturing-not-up-to-snuff-for-covid-19-vaccines-therapies/2477753/Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development. But success in the clinic means nothing if drugmakers can’t produce a therapy or vaccine fast enough—and the company’s helmsman i
- Quest Diagnostics Launches First Consumer-Ordered COVID-19 Antibody Testhttps://modernod.com/news/quest-diagnostics-launches-first-consumer-ordered-covid-19-antibody-test/2477674/For about $120, anyone can get now get a COVID-19 antibody test from Quest Diagnostics. The lab company announced Tuesday it launched the first consumer-ordered test—yes, that means there’s no doctor referral needed—to allow patients to check whether they have the antibodies that indicate t
- Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harderhttps://modernod.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women. But experts don’t know why. At Johns Hopkins University, researchers have begun to
- Lilly Partners With NIH to Test Olumiant in Patients Hospitalized With COVID-19https://modernod.com/news/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/2477574/Drug companies worldwide are testing existing medicines as potential treatments for COVID-19—plus working on new therapeutics—with few answers yet. Now, Eli Lilly is among the latest to kick off a trial through a partnership with federal health officials, according t